|
DDX18 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.611560E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.901600E-03 |
| Normal-vs-Stage2 |
2.631000E-01 |
| Normal-vs-Stage3 |
6.745800E-01 |
| Normal-vs-Stage4 |
2.981600E-01 |
| Stage1-vs-Stage2 |
6.504400E-01 |
| Stage1-vs-Stage3 |
4.358800E-03 |
| Stage1-vs-Stage4 |
1.464230E-03 |
| Stage2-vs-Stage3 |
1.547570E-01 |
| Stage2-vs-Stage4 |
7.270300E-02 |
| Stage3-vs-Stage4 |
5.479200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.039170E-01 |
| Normal-vs-AfricanAmerican |
3.360800E-01 |
| Normal-vs-Asian |
2.557800E-01 |
| Caucasian-vs-AfricanAmerican |
5.571500E-02 |
| Caucasian-vs-Asian |
7.363200E-01 |
| AfricanAmerican-vs-Asian |
2.357200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.852400E-01 |
| Normal-vs-Female |
2.210400E-02 |
| Male-vs-Female |
3.749700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.648800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.156020E-01 |
| Normal-vs-Age(61-80Yrs) |
2.076000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.070000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.522200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.076800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.107800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.140000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.504400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.171800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.659620E-02 |
| Normal-vs-Grade 2 |
5.958800E-04 |
| Normal-vs-Grade 3 |
9.789000E-01 |
| Normal-vs-Grade 4 |
3.798200E-02 |
| Grade 1-vs-Grade 2 |
7.063400E-01 |
| Grade 1-vs-Grade 3 |
7.042400E-02 |
| Grade 1-vs-Grade 4 |
8.519200E-03 |
| Grade 2-vs-Grade 3 |
2.404800E-04 |
| Grade 2-vs-Grade 4 |
3.73030000000441E-06 |
| Grade 3-vs-Grade 4 |
3.046200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.61720000513688E-08 |
| Normal-vs-ccB subtype |
1.034760E-01 |
| ccA subtype-vs-ccB subtype |
1.72517555796503E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.925590E-01 |
| Normal-vs-N1 |
8.331400E-01 |
| N0-vs-N1 |
4.888600E-01 |
|
|
